 In 2001, CDC published an article in the Journal of Virology showing that a single dose of a DNA vaccine could prevent WNV infection in mice and horses.

Slides:

Advertisements

Similar presentations

Presentation to the Executive Committee PAHO/WHO, June 2003 West Nile Virus (WNV) in Latin America and the Caribbean PAHO Communicable Disease Unit.

Advertisements

Up date on malaria vaccine

Adriana Weinberg, MD University of Colorado Denver.

NH Department of Health and Human Services Protect Yourself Against Eastern Equine Encephalitis (EEE) and West Nile virus (WNV)

AN ANALYTICAL STUDY OF THE PERCEPTIONS, PREVENTIONS STRATEGIES, TREATMENT AND ECONOMIC IMPACT OF EQUINE WEST NILE VIRUS R. GALVAN, A. Rene, S. Bae, K.

Food, Agricultural and Environmental Security Cook College New Jersey Agricultural Experiment Station.

Case Study #9 West Nile Virus

West Nile Virus Timeline  1937  First Case reported  1950  Virus studied in Egypt  1957  Outbreak in Israel  1960  Equine cases  1999  Appeared.

Preventing West Nile Virus in Horses & Horse Owners.

Causative Agent Virus Infects Humans, Birds, Mosquitoes, Horses and Other Mammals.

CBER Regulatory Laboratory Planning & Preparedness for SARS-related Biologics Products Kathryn M. Carbone MD Associate Director for Research, Acting, Center.

New Malaria Vaccine Is Shown to Work in Infants Under 1 Year Old By DONALD G. McNEIL Jr.DONALD G. McNEIL Jr. Published: October 18, 2007.

Protect your Family from West Nile Virus. West Nile virus West Nile virus Mosquito vector Incidental infections Bird reservoir hosts Incidental infections.

West Nile Virus (WNV) Facts, Signs, and Prevention

The HPV Vaccine: Protecting Girls from Cervical Cancer

Vijay B. Samant President and Chief Executive Officer September 2005.

Not all Journals are Created Equal! Using Impact Factors to Assess the Impact of a Journal.

By Aizaz Khan. Maurice Hilleman discover measle vaccine. Maurice Hilleman Maurice Hilleman's measles vaccine is estimated to prevent 1 million deaths.

Dr Hannah Kibuuka Makerere University Walter Reed Project Presentation at the Uganda Medical Association-Uganda Veterinary Association joint conference.

18.3 Viral Diseases KEY CONCEPT Some viral diseases can be prevented with vaccines.

Stephanie Hyman, MPH student Walden University PUBH Instructor: Dr. Howard Rubin Fall Qtr

The HCV vaccine: cooperation in the shadow of the pyramids Antonella Folgori.

Aberdeen Confidence in Concept Fund Prof Phil Hannaford Vice Principal – Research & Knowledge Exchange.

INTEGRATED PROJECT MUCOSAL VACCINES FOR POVERTY-RELATED DISEASES MUVAPRED MUVAPRED Project Summary Human Immunodeficiency Virus and Mycobacterium tuberculosis.

Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.

Myron S. Cohen, MD Associate Vice Chancellor Director, Institute for Global Health The University of North Carolina.

Chapter 12 DNA: The Genetic Material Identification of the Genetic Material (DNA) In 1928, an experiment unrelated to genetics led to the discovery of.

“FluBlØk: A Recombinant Hemagglutinin Protein Vaccine for Influenza” Manon Cox VRBPAC February 27, 2007 A Vaccine Company for the 21st Century “Making.

HOW DO VIRUSES CROSS THE SPECIES BARRIER? Rachel Rezabek.

Viruses A virus is a NON-Living particle made of DNA or RNA and a protein coat. Look at table 25-1 on p. 487 in text book. VERY small. ~ 0.001micron.

West Nile Virus: Pathogenesis and Diagnostic Tools Maria Rios, PhD - Senior Staff Fellow Laboratory of Molecular Virology DETTD/OBRR/CBER/FDA WNV epidemic.

Publications Citations Tom Cook: Web of Science (ISI) Citation Analysis Summary: 124 Articles, 2,068 Citations, h-index = 26.

How does a virus that originally infected animals change in such a way that it can infect humans? Topic: Topic: H1N1 (Swine Flu) Rationale:  H1N1 or swine.

H1N1 Virus (Swine Flu) By: Emalee Ramirez & Ashley Towe.

HOW DO VIRUSES CROSS THE SPECIES BARRIER? Rachel Rezabek.

The HPV Vaccine: Protecting Your Daughter from Cervical Cancer Your questions deserve trusted answers.

© Arbovax Inc © Arbovax Inc Arbovax Arbovax ® Advanced technology for insect-borne virus vaccines Vaccines and Vaccination Valencia, Spain.

Preparing for WNV: Montana’s Experience Jim Murphy, Health Specialist Montana Department of Public Health & Human Services (406)

PEER: Skills for Success University of Tennessee-Knoxville West Nile Virus Ethel Stanley BioQUEST, Beloit College Sam Donovan University of Pittsburgh.

West Nile Virus Surveillance and Response U.S. National and Michigan 2002 Michigan Department of Agriculture Animal Industry Division Steven Halstead,

Division of Hematology Emergency Preparedness Action Initiatives Prepared by Mark Weinstein, Ph.D., Dorothy Scott M.D. and Basil Golding M.D. Division.

RESEARCH EVALUATION - THE METRICS UNITED KINGDOM OCTOBER 2010.

Research Question Does age increase the likely hood of being poisoned by lead? Do males or female Condors have a higher chance of being poisoned by lead.

Human clinical trial of DNA-MVA HIV vaccine candidate begins A Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector.

Updated 01/12/07 West Nile Virus Activity in California Counties 2007 YTD Counties with West Nile virus activity (number of human infections) Counties.

 Mosquito  Horses  The warm months  dawn and dusk.  Hot, dry weather Reference: "West Nile Virus Information."

Animal Models in Modern Vaccine Development. Animal Models The recognition that animals could be used as potential models for human infectious diseases.

Genetics of Viruses. Viral Structure n Virus: – “poison” (Latin) – infectious particles consisting of a nucleic acid in a protein coat n Capsid= viral.

Viruses. What are viruses? They are not living things. Viruses are considered non-living because they do not use energy to grow or to respond to their.

Viruses: An Introduction Biology 11 Mr. Andersen Click Here To Begin.

CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.

$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.

WHY YOU SHOULD VACCINATE YOUR CHILDREN BY DANA KOISHOR.

Dupilumab With Topical Corticosteroids Superior To Treatment With TCS Paris, France, and Tarrytown, N.Y., – June 6, 2016 – Sanofi and Regeneron “outed”

Large animal model Equine infectious anemia virus (EIAV) Visna-maedi virus (VMV) Caprine arthritis-encephalitis virus (CAEV)

Date of download: 7/11/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Different types of virus–host interactions: apparent (clinical.

International Journal of Veterinary Health Science & Research

Copyright © 2017 American Academy of Pediatrics.

REVOLUTiONiZiNG MALARiA VACCiNATiON

Communicable Diseases

West Nile Virus Johnson 7.

Novel vaccine adjuvants for infectious diseases aninal

Research impact and library support

? Neutralizing Antibodies: Research pathways in 2013 and beyond

DENGUE VACCINE.

Universal influenza virus vaccines and therapeutic antibodies

Viral Diseases How do vaccines work?.

Prioritizing Prevention of HPV-Related Disease

Dengue Antibodies, then Zika: A Fatal Sequence in Mice

Presentation transcript:

 In 2001, CDC published an article in the Journal of Virology showing that a single dose of a DNA vaccine could prevent WNV infection in mice and horses Case Study West Nile Virus (WNV) Disseminating Science Creating Awareness Catalyzing Action Effecting Change Shaping the Future

Quick Stats Total Citations nd Generation Citations4,210 5 Year Impact Factor5.257 Average Cites Per Year16.17 Case Study WNV Paper Metrics

 In 2002, the California Condor Recovery Team learned that an experimental CDC DNA WNV vaccine was proven to protect against WNV infection in several bird species Case Study West Nile Virus (WNV) Disseminating Science Creating Awareness Catalyzing Action Effecting Change Shaping the Future

 CDC expedited the delivery of the equine WNV vaccine  In 2004, the vaccine was shown to be safe and effective in protecting captive condors from naturally circulating WNV  CDC expedited the delivery of the equine WNV vaccine  In 2004, the vaccine was shown to be safe and effective in protecting captive condors from naturally circulating WNV Case Study West Nile Virus (WNV) Disseminating Science Creating Awareness Catalyzing Action Effecting Change Shaping the Future

 In 2005, the CDC equine DNA vaccine was licensed by the USDA  This led to a Phase 1 clinical trial of a similar DNA vaccine in humans  The vaccine was shown to induce T- cell and antibody responses at levels shown to be protective in studies of horses  In 2005, the CDC equine DNA vaccine was licensed by the USDA  This led to a Phase 1 clinical trial of a similar DNA vaccine in humans  The vaccine was shown to induce T- cell and antibody responses at levels shown to be protective in studies of horses Case Study West Nile Virus (WNV) Disseminating Science Creating Awareness Catalyzing Action Effecting Change Shaping the Future

 In 2008, the WNV team received the CDC Director’s Innovation Award Case Study West Nile Virus (WNV) Disseminating Science Creating Awareness Catalyzing Action Effecting Change Shaping the Future

 In 2011, the CDC/NIH DNA vaccine was further modified  It demonstrated an enhanced T- cell response in Phase 1 clinical trials  In 2011, the CDC/NIH DNA vaccine was further modified  It demonstrated an enhanced T- cell response in Phase 1 clinical trials Case Study West Nile Virus (WNV) Disseminating Science Creating Awareness Catalyzing Action Effecting Change Shaping the Future